Table 2 Parasitological and clinical outcomes of enrolled patients
Outcome | Kibaha (n = 83) | Mlimba (n = 85) | Mkuzi (n = 88) | Ujiji (n = 88) | ||||
|---|---|---|---|---|---|---|---|---|
n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | |
PCR Uncorrected | ||||||||
 ETF | 0 | – | 0 | – | 0 | – | 0 | – |
 LCF | 8 (9.6) | 4.9–18.2 | 3 (3.5) | 1.1–10.5 | 8 (9.1) | 4.6–17.2 | 6 (6.8) | 3.1–14.5 |
 LPF | 4 (4.8) | 1.8–12.2 | 9 (10.6) | 5.6–19.2 | 23 (26.1) | 18–36.4 | 17 (19.3) | 12.3–29 |
 ACPR | 71 (85.5) | 76.1–91.6 | 73 (85.9) | 76.7–91.8 | 57 (64.8) | 54.2–74.1 | 65 (73.9) | 63.6–82 |
 Total | 83 |  | 85 |  | 88 |  | 88 |  |
 Excluded |  |  |  |  |  |  |  |  |
 Withdrawn/lost | 2 |  | 3 |  | 0 |  | 0 |  |
 Cumulative cure rate | 85.6 | 76.0–91.5 | 85.9 | 76.5–91.7 | 64.8 | 53.8–73.7 | 73.9 | 63.3–81.8 |
PCR Corrected | ||||||||
 ETF | 0 | – | 0 | – | 0 | – | 0 | – |
 LCF | 1 (1.4) | 0.2–9.4 | 0 | – | 0 | – | 0 | – |
 LPF | 1(1.4) | – | 0 | – | 1 (1.7) | 0.2–11.5 | 1 (1.5) | 0.2–10.2 |
 ACPR | 71 (97.3) | 90.6–99.8 | 73 (100) | – | 57 (98.3) | 88.5–99.8 | 65 (98.5) | 89.8–99.8 |
 Total | 73 |  | 73 |  | 58 |  | 66 |  |
 Excluded |  |  |  |  |  |  |  |  |
 Reinfections | 10 |  | 11 |  | 28 |  | 21 |  |
 PCR unknown | 0 |  | 1 |  | 1 |  | 1 |  |
 Missing PCR | 0 |  | 0 |  | 1 |  | 0 |  |
 Withdrawn/lost | 2 |  | 3 |  | 0 |  | 0 |  |
 Cumulative cure rate (Kaplan–Meier) | 97.6 | 90.5–99.4 | 100 | - | 98.6 | 90.7–99.8 | 98.8 | 91.9–99.8 |